Original Article

Vol. 33 No. 11 (2022): 2022.33.11-Turkish Journal of Gastroenterology

Mucocutaneous Manifestations and Associated Factors in Patients with Crohn’s Disease

Main Article Content

Yusuf Kayar
Ramazan Dertli
Şevki Konür
Mehmet Ağın
Abdullah Al Kafee
Bülent Baran
Aslı Çiftçibaşı Örmeci
Filiz Akyüz
Kadir Demir
Fatih Beşışık
Sabahattin Kaymakoğlu

Abstract

Background: One-third of all extraintestinal manifestations are mucocutaneous findings in patients with Crohn’s disease and there is a relationship between some risk factors. Our aim is to evaluate factors associated with mucocutaneous manifestations in our cohort of patients with Crohn’s disease with a follow-up duration of up to 25 years.
Methods: In the study, 336 patients with Crohn’s disease who were followed up between March 1986 and October 2011 were included. The demographic characteristics, Crohn’s disease-related data, and accompanying mucocutaneous manifestations were recorded. The cumulative probability of mucocutaneous extraintestinal manifestations and possible risk factors were analyzed.
Results: Oral and skin involvement were detected in 109 (32%) and 31 (9.2%) patients, respectively. The cumulative probability of developing oral and skin manifestations were 43.2% and 20.3%, respectively. Cox regression analysis showed that female gender (odds ratio: 3.28, 95% CI: 1.51-7.14, P = .003) and corticosteroid use (odds ratio: 7.88, 95% CI: 1.07-57.97, P = .043) are independently associated with the development of skin manifestations, while family history (odds ratio: 3.59, 95% CI: 2.18-5.93, P < .001) and inflammatory-type disease (odds ratio: 1.776, 95% CI: 1.21-2.61, P = .004) were independently associated with the development of oral ulcers.
Conclusion: Mucocutaneous extraintestinal manifestations are associated with female gender, corticosteroid use, family history, and disease type in a large cohort of patients with Crohn’s disease. Defining the specific relationships of immune-mediated diseases will help to better understand the pathogenesis of Crohn’s disease and associated mucocutaneous manifestations and to use more effective treatments.
Cite this article as: Kayar Y, Dertli R, Konür S, et al. Mucocutaneous manifestations and associated factors in patients with Crohn’s disease. Turk J Gastroenterol. 2022;33(11):945-954.

Article Details

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 > >> 

You may also start an advanced similarity search for this article.